A Statewide Collaborative Quality Initiative to Improve Antibiotic Duration and Outcomes in Patients Hospitalized With Uncomplicated Community-Acquired Pneumonia
Open Access
- 13 November 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 75 (3) , 460-467
Abstract
Background: Community-acquired pneumonia (CAP) is a common cause for hospitalization and antibiotic overuse. We aimed to improve antibiotic duration for CAP across 41 hospitals participating in the Michigan Hospital Medicine Safety Consortium (HMS). Methods: This prospective collaborative quality initiative included patients hospitalized with uncomplicated CAP who qualified for a 5-day antibiotic duration. Between 23 February 2017 and 5 February 2020, HMS targeted appropriate 5-day antibiotic treatment through benchmarking, sharing best practices, and pay-for-performance incentives. Changes in outcomes, including appropriate receipt of 5 ± 1–day antibiotic treatment and 30-day postdischarge composite adverse events (ie, deaths, readmissions, urgent visits, and antibiotic-associated adverse events), were assessed over time (per 3-month quarter), using logistic regression and controlling for hospital clustering. Results: A total of 41 hospitals and 6553 patients were included. The percentage of patients treated with an appropriate 5 ± 1–day duration increased from 22.1% (predicted probability, 20.9% [95% confidence interval: 17.2%–25.0%]) to 45.9% (predicted probability, 43.9% [36.8%–51.2%]; adjusted odds ratio [aOR] per quarter, 1.10 [1.07–1.14]). Thirty-day composite adverse events occurred in 18.5% of patients (1166 of 6319) and decreased over time (aOR per quarter, 0.98 [95% confidence interval: .96–.99]) owing to a decrease in antibiotic-associated adverse events (aOR per quarter, 0.91 [.87–.95]). Conclusions: Across diverse hospitals, HMS participation was associated with more appropriate use of short-course therapy and fewer adverse events in hospitalized patients with uncomplicated CAP. Establishment of national or regional collaborative quality initiatives with data collection and benchmarking, sharing of best practices, and pay-for-performance incentives may improve antibiotic use and outcomes for patients hospitalized with uncomplicated CAP.Keywords
Funding Information
- BCBSM
- Michigan Hospital Medicine Safety Consortium
- HMS Consortium
- AHRQ (K08HS026530)
This publication has 32 references indexed in Scilit:
- Duration of Antibiotic Treatment in Community-Acquired PneumoniaJAMA Internal Medicine, 2016
- Sustained Impact of an Antibiotic Stewardship Intervention for Community-Acquired PneumoniaInfection Control & Hospital Epidemiology, 2016
- APPROVED: New Antimicrobial Stewardship Standard.2016
- A Program to Prevent Catheter-Associated Urinary Tract Infection in Acute CareNew England Journal of Medicine, 2016
- Prevalence of Antimicrobial Use in US Acute Care Hospitals, May-September 2011JAMA, 2014
- Vital Signs: Improving Antibiotic Use Among Hospitalized Patients2014
- Impact of an Antimicrobial Stewardship Intervention on Shortening the Duration of Therapy for Community-Acquired PneumoniaClinical Infectious Diseases, 2012
- Efficacy of Short-Course Antibiotic Regimens for Community-Acquired Pneumonia: A Meta-analysisThe American Journal of Medicine, 2007
- Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in AdultsClinical Infectious Diseases, 2007
- An Intervention to Decrease Catheter-Related Bloodstream Infections in the ICUNew England Journal of Medicine, 2006